BDBM732671 (R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromethyl)phenyl)ethyl)-[1,2,4]triazolo[1,5-a]pyridine-7-sulfonamide (Example 215) and (R)—N-ethyl-N-(2,2,2-trifluoro-1-(4-(trifluoromethyl)phenyl)ethyl)-[1,2,4]triazolo[1,5-a]pyridine-7-sulfonamide (Example 216)::US20250115569, Example 215

SMILES CN([C@H](c1ccc(C(F)(F)F)cc1)C(F)(F)F)S(=O)(=O)c1ccn2ncnc2c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 732671   

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732671((R)—N-methyl-N-(2,2,2-trifluoro-1-(4-(trifluoromet...)
Affinity DataIC50: 70.8nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent